Cargando…

Cardiovascular Health, Part 1: Preparticipation Cardiovascular Screening

CONTEXT: Identification of potentially fatal cardiac conditions in otherwise healthy athletes presents a major challenge to the sports medicine community. The requirements for preparticipation screening vary among countries and even from state to state within the United States. The mandated use of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Sanjaya, Baman, Timir, Day, Sharlene M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445149/
https://www.ncbi.nlm.nih.gov/pubmed/23015913
http://dx.doi.org/10.1177/1941738109350405
_version_ 1782243777968078848
author Gupta, Sanjaya
Baman, Timir
Day, Sharlene M.
author_facet Gupta, Sanjaya
Baman, Timir
Day, Sharlene M.
author_sort Gupta, Sanjaya
collection PubMed
description CONTEXT: Identification of potentially fatal cardiac conditions in otherwise healthy athletes presents a major challenge to the sports medicine community. The requirements for preparticipation screening vary among countries and even from state to state within the United States. The mandated use of an electrocardiogram as a screening implement has provoked international controversy. EVIDENCE ACQUISITION: Part 1 of this review highlights the current guidelines and controversies surrounding cardiovascular screening, with a focus on the diagnostic challenges associated with identifying athletes with inheritable cardiomyopathies. Data sources were limited to peer-reviewed publications from 1984 to the present. RESULTS: Preparticipation screening should include at least a history and a physical examination for all athletes, whereas use of an electrocardiogram is still controversial. Diagnosis of inherited cardiomyopathies presents unique challenges, particularly in hypertrophic cardiomyopathy, where many features can mimic those found in the “athlete’s heart.” CONCLUSIONS: Recognizing cardiac conditions in athletes that can predispose them to sudden cardiac death or other adverse outcomes is of vital importance, as is the appropriate exclusion of these athletes from competition. Further studies are needed to determine the most efficient and cost-effective means of screening and to increase the sensitivity and specificity of diagnostic testing for inheritable cardiovascular diseases.
format Online
Article
Text
id pubmed-3445149
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-34451492012-09-26 Cardiovascular Health, Part 1: Preparticipation Cardiovascular Screening Gupta, Sanjaya Baman, Timir Day, Sharlene M. Sports Health Primary Care CONTEXT: Identification of potentially fatal cardiac conditions in otherwise healthy athletes presents a major challenge to the sports medicine community. The requirements for preparticipation screening vary among countries and even from state to state within the United States. The mandated use of an electrocardiogram as a screening implement has provoked international controversy. EVIDENCE ACQUISITION: Part 1 of this review highlights the current guidelines and controversies surrounding cardiovascular screening, with a focus on the diagnostic challenges associated with identifying athletes with inheritable cardiomyopathies. Data sources were limited to peer-reviewed publications from 1984 to the present. RESULTS: Preparticipation screening should include at least a history and a physical examination for all athletes, whereas use of an electrocardiogram is still controversial. Diagnosis of inherited cardiomyopathies presents unique challenges, particularly in hypertrophic cardiomyopathy, where many features can mimic those found in the “athlete’s heart.” CONCLUSIONS: Recognizing cardiac conditions in athletes that can predispose them to sudden cardiac death or other adverse outcomes is of vital importance, as is the appropriate exclusion of these athletes from competition. Further studies are needed to determine the most efficient and cost-effective means of screening and to increase the sensitivity and specificity of diagnostic testing for inheritable cardiovascular diseases. SAGE Publications 2009-11 /pmc/articles/PMC3445149/ /pubmed/23015913 http://dx.doi.org/10.1177/1941738109350405 Text en © 2009 The Author(s)
spellingShingle Primary Care
Gupta, Sanjaya
Baman, Timir
Day, Sharlene M.
Cardiovascular Health, Part 1: Preparticipation Cardiovascular Screening
title Cardiovascular Health, Part 1: Preparticipation Cardiovascular Screening
title_full Cardiovascular Health, Part 1: Preparticipation Cardiovascular Screening
title_fullStr Cardiovascular Health, Part 1: Preparticipation Cardiovascular Screening
title_full_unstemmed Cardiovascular Health, Part 1: Preparticipation Cardiovascular Screening
title_short Cardiovascular Health, Part 1: Preparticipation Cardiovascular Screening
title_sort cardiovascular health, part 1: preparticipation cardiovascular screening
topic Primary Care
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445149/
https://www.ncbi.nlm.nih.gov/pubmed/23015913
http://dx.doi.org/10.1177/1941738109350405
work_keys_str_mv AT guptasanjaya cardiovascularhealthpart1preparticipationcardiovascularscreening
AT bamantimir cardiovascularhealthpart1preparticipationcardiovascularscreening
AT daysharlenem cardiovascularhealthpart1preparticipationcardiovascularscreening